TAK-778 induces osteogenesis in ovariectomized rats via an estrogen receptor-dependent pathway
TAK-778, a derivative of ipriflavone, has been shown to induce bone growth both in vitro and in vivo. Recently, it has been shown that TAK-778 can enhance osteoblast differentiation of human bone marrow cells via an estrogen receptor (ER)-dependent pathway. However, the mechanism by which TAK-778 ex...
|Journal Title:||Journal of Bone and Mineral Metabolism|
|Authors and Corporations:|
|In:||Journal of Bone and Mineral Metabolism, 29, 2011, 2, p. 168-173|
|Type of Resource:||E-Article|